Sclerotherapy and Candida Antigen in Treatment of Common Warts
NCT06749665
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
75
Enrollment
OTHER
Sponsor class
Conditions
Common Wart
Interventions
DRUG:
polidacanol 3%
BIOLOGICAL:
candida antigen
Sponsor
Sohag University